Dr. Lan Huang Ph.D.
Dr. Lan Huang is Co-founder, Chair and CEO of BeyondSpring. Dr. Huang has more than a decade of entrepreneurial experience in the Chinese and U.S. biotechnology industry and invented and holds patents for a number of biotech products for oncology and dermatology indications. Prior to founding BeyondSpring, Dr. Huang co-founded Wuxi MTLH Biotechnology Co. Ltd., whose self-designed cancer peptide drug’s China rights were acquired in 2010 by Shanghai Pharmaceutical Group. She also co-founded Paramax International, a clinical CRO company in China. In addition, Dr. Huang worked with Forward Ventures, where she led partnering initiatives between Forward’s portfolio companies and Chinese pharmaceutical companies. She is the 2009 recipient of China’s “Thousand Talent Innovator Award” and in 2021 was named to PharmVOICE magazine’s 100 Most Inspiring People in the Life Sciences Industry. She holds a BA in Biology & Chemistry from Lawrence University and a Ph.D. in Chemistry from the University of California, Berkeley.
Year appointed: 2013